N.J. Jury Awards $10.5M In Third Accutane Trial

By Christine Caulfield

Law360, New York (April 23, 2008, 12:00 AM ET) -- Drugmaker Hoffmann-La Roche Inc. lost the third of potentially hundreds of trials over its controversial Accutane on Tuesday, when a New Jersey jury awarded $10.5 million to a woman who alleged the acne treatment caused her inflammatory bowel disease.

Plaintiffs attorney Pete Kaufman said the award is the largest so far in the three cases to go to trial since May last year and should serve as a warning to the Nutley, N.J.-based pharmaceutical company to reconsider its strategy to fight the lawsuits in court....
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles